If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

Share Price is delayed by 15 minutes
Get Live Data
15.10    0.30 (2.03%)
Bid:
14.60
Ask:
15.45
Spread: 0.85 (5.822%)
Market Cap: £51.35m
BVC Live PriceLast checked at - London Stock Exchange

Intraday Batm Advanced Share Chart

Launch of mobile agri-waste treatment solution

7 Mar 2017 07:00

RNS Number : 6790Y
BATM Advanced Communications Ld
07 March 2017
 

7 March 2017

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

BATM launches World's first Mobile Agri-Waste Solution and Wins $2.5m Contract

 

BATM Advanced Communications Limited (LSE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, is pleased to announce that its Pathogenic Waste Treatment and Sterilisation unit has launched the world's first mobile agri-waste treatment solution and has been awarded a contract worth $2.5m. BATM has received an advance payment of $1m with delivery of the product expected to commence during H2 2017 and due to complete in Q1 2018.

 

The contract is for the delivery of a mobile unit giving the customer the ability to deploy the solution for the safe disposal of mass poultry affected by disease and illness. Poultry affected by disease and illness cannot be transported from their location and are disposed of on-site either via burning or burial. The treatment process is completely eco-friendly with no hazardous materials or chemicals used and creates no odour.

 

This order follows the successful installation and operation over the last several months of an agri-waste treatment solution at a major rendering site. BATM received two significant orders for stationary units, one for treating poultry and another contract to treat bovine remains. Both contracts are advancing well with full commercial deployment of the first one expected in H1 2017.

 

BATM's agri-waste treatment solutions utilise the Group's proprietary medical sterilisation solution ("ISS") in the rendering process, allowing the safe treatment of animal remains to generate valuable protein and fat. These proteins and fats can be used for animal or fish food and provide an additional source of revenue for the Group's customers.

 

Dr. Zvi Marom, CEO of BATM, said: "We are very pleased to have received this significant order for our mobile agri-waste treatment solution from such a major customer. Our agri-waste solution is unique and, in addition to its cost advantages and savings, provides a perfect ecological solution. We believe that making our solution mobile presents our customers with a new, efficient and eco-friendly way of dealing with animal diseases.

 

"Our ISS technology has become the leading biologic and pathogenic waste solution in the medical market and is now deployed by more than 400 hospitals. As demonstrated by our agri-waste solutions, we are finding new applications for this technology on a much larger scale in both the biopharma and agricultural fields. Our ISS solution recently received a patent in the US and we expect our agri-waste solution to do the same in due course.

 

"BATM management expects to receive more orders based on the ISS technology this year."

 

 

Enquiries:

 

BATM Advanced Communications

 

Dr Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

 

 

 

finnCap

 

Stuart Andrews, Scott Mathieson

+44 20 7220 0500

 

 

Shore Capital

 

Mark Percy, Anita Ghanekar

+44 20 7408 4050 

 

 

Luther Pendragon

 

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLFFELVFIRIID
Date   Source Headline
25th Jun 20267:00 amRNS-RNew contract with leading US Broadband Provider
22nd Jun 20267:00 amRNSSale of Non-Core Businesses
26th May 20267:00 amRNSBlock Listing Interim Review
21st Apr 20267:00 amRNSPublication of Annual Report
11th Mar 20267:00 amRNSFull Year Results
3rd Mar 202612:00 pmRNSHolding(s) in Company
10th Feb 20267:00 amRNSSale of Non-core Business
3rd Feb 20267:00 amRNSHolding(s) in Company
2nd Feb 20267:00 amRNSHolding(s) in Company
19th Jan 20267:00 amRNS-RBATM selected as FPT Israel cybersecurity partner
12th Jan 20267:00 amRNSHolding(s) in Company
12th Jan 20267:00 amRNSHolding(s) in Company
8th Jan 202611:00 amRNSTransaction in own shares and Total Voting Rights
2nd Jan 20267:01 amRNSDirector Declaration
2nd Jan 20267:01 amRNSDirector Declaration
2nd Jan 20267:00 amRNSCompletion of Sale of Diagnostics Distributor
2nd Jan 20267:00 amRNSCompletion of Sale of Diagnostics Distributor
29th Dec 20257:00 amRNSAppointment of Chairman and Directorate Change
29th Dec 20257:00 amRNSAppointment of Chairman and Directorate Change
10th Dec 202512:00 pmRNSAGM Result, Directorate Change & AMS Sale Update
1st Dec 20257:00 amRNSTotal Voting Rights
25th Nov 20257:00 amRNSBlock Listing Interim Review
17th Nov 20257:00 amRNSNew Carrier Ethernet Order
5th Nov 20257:00 amRNSNotice of AGM and Directorate Changes
6th Oct 20257:00 amRNSSale of Diagnostics Distributor
26th Sep 20257:00 amRNSDirectorate Change
18th Aug 20257:00 amRNSInterim Results
4th Aug 20257:00 amRNSTotal Voting Rights
24th Jul 20257:00 amRNSSale of Non-Core Businesses and Notice of Results
23rd Jun 20257:00 amRNSDirectorate Change
27th May 20257:00 amRNSBlock Listing Interim Review
12th May 20257:00 amRNSOrder for ultra-high speed encryption development
6th May 20257:00 amRNS-RBATM unveils new brand identity
8th Apr 202511:00 amRNSAnnual Report Publication and AGM Update Statement
27th Mar 20257:00 amRNSNew strategic customer for Edgility in Brazil
17th Mar 20257:00 amRNSFull Year Results
5th Mar 20257:00 amRNSUpdate on Strategy and Trading
24th Feb 20257:00 amRNSHolding(s) in Company
16th Jan 20257:00 amRNSADOR appoints Nadhim Zahawi to lead Advisory Board
19th Dec 20243:30 pmRNSResult of AGM and Director Appointment
19th Dec 20247:00 amRNSNew Tier 1 Customer for Edgility in Mexico
11th Dec 20247:00 amRNSNATlab commences pre-clinical validation
3rd Dec 20247:00 amRNSBlock Listing Interim Review
2nd Dec 20247:00 amRNSBATM receives orders of $2.4m for Edgility
25th Nov 20247:00 amRNSBlock listing Interim Review
14th Nov 202411:00 amRNSNotice of AGM and Proposed Director Appointment
4th Nov 20247:00 amRNSTotal Voting Rights
19th Aug 20247:00 amRNSInterim Results
10th Jul 20247:00 amRNSAmazon Web Services partnership for Edgility
2nd Jul 20247:00 amRNSCommercial markets cybersecurity partnership

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.